Let's Talk.
We're open to conversations with scientists, pharmaceutical partners, investors, and institutions who share our vision for programmable biology.
What We're Open To
- Pharma & biotech co-development partnerships
- Enterprise SaaS pilots with research institutions
- Seed & Series A investor conversations
- Scientific collaborations & advisory roles
- Grant applications & non-dilutive funding
- Media, press & speaking invitations